Unknown

Dataset Information

0

A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.

ABSTRACT: Noonan syndrome is a relatively common and heterogeneous genetic disorder, including congenital heart defect in more than half of the cases. If the defect is not large, life expectancy is normal. Here we report on a case of an infant with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy with lethal outcome, in whom we identified a novel mutation in the KRAS gene. This heterozygous unclassified missense variant in exon 3: c.179G> T (p.Gly60Val) might be associated with a lethal form of Noonan syndrome. The malignant clinical course of the disease and the lethal outcome in an infant only a few months old might be connected to RAS-mitogen-activated protein kinase pathway hyperactivation, consequently promoting cell growth and proliferation, leading to rapidly progressive hypertrophic cardiomyopathy. Further biochemical and functional studies are needed to confirm this hypothesis.

SUBMITTER: Nosan G 

PROVIDER: S-EPMC3893993 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.

Nosan Gregor G   Bertok Sara S   Vesel Samo S   Yntema Helger G HG   Paro-Panjan Darja D  

Croatian medical journal 20131201 6

Noonan syndrome is a relatively common and heterogeneous genetic disorder, including congenital heart defect in more than half of the cases. If the defect is not large, life expectancy is normal. Here we report on a case of an infant with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy with lethal outcome, in whom we identified a novel mutation in the KRAS gene. This heterozygous unclassified missense variant in exon 3: c.179G> T (p.Gly60Val) might be associated with a lethal  ...[more]

Similar Datasets

Unknown A Novel Noonan Syndrome RAF1 Mutation: Lethal Course in a Preterm Infant.
| S-EPMC4508625 | biostudies-literature
Unknown An atypical case of Noonan syndrome with KRAS mutation diagnosed by targeted exome sequencing.
| S-EPMC5642084 | biostudies-literature
Unknown Membranous septal aneurysm in a child with Noonan syndrome and hypertrophic cardiomyopathy.
| S-EPMC9218020 | biostudies-literature
Unknown Hypertrophic cardiomyopathy in an adult patient with Noonan syndrome with multiple lentigines.
| S-EPMC10290193 | biostudies-literature
Unknown Double-chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome.
| S-EPMC7160468 | biostudies-literature
Unknown A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.
| S-EPMC7045029 | biostudies-literature
Unknown Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report.
| S-EPMC10567658 | biostudies-literature
Unknown Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.
| S-EPMC7455087 | biostudies-literature
Unknown Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome.
| S-EPMC9266615 | biostudies-literature
Unknown Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
| S-EPMC1474118 | biostudies-literature